🇺🇸 FDA
Patent

US 8088935

Compounds and methods for the treatment of asthma

granted A61KA61K31/353A61K31/4741

Quick answer

US patent 8088935 (Compounds and methods for the treatment of asthma) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/353, A61K31/4741, A61K31/506, A61P